By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo

TheMediTary.Com

Medical Information, Documents, News - TheMediTary.Com

  • Home
  • News
  • Drugs
  • Drugs A-Z
  • Medical Answers
  • About Us
  • Contact
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo
Search Drugs
  • Drugs
    • Latest Drugs
    • Drugs A-Z
    • Medical Answers
  • News
    • FDA Alerts
    • Medical News
    • Health
    • Consumer Updates
    • Children's Health
  • More TheMediTary.Com
    • About Us
    • Contact
Follow US
Home > Drugs > Lutetium Lu 177 Vipivotide Tetraxetan Injection
Drugs

Lutetium Lu 177 Vipivotide Tetraxetan Injection

https://themeditary.com/drug/lutetium-lu-177-vipivotide-tetraxetan-injection-12830.html
Medically Reviewed by Glamora Samuels, MD TheMediTary.Com | Reviewed: Sep 11, 2023  Additional Content by TheMediTary.Com

Pregnancy & Lactation: Risk data not available

Contents
Uses Warnings Before Taking Dosage Side effects Interactions

What is Lutetium Lu 177 Vipivotide Tetraxetan Injection?

Lutetium Lu 177 vipivotide tetraxetan injection is used to treat a certain type of prostate cancer (cancer of a male reproductive gland) that has spread to other parts of the body and that has already been treated with other medications. Lutetium Lu 177 vipivotide tetraxetan is in a class of medications called radiopharmaceuticals. It works by targeting and delivering radiation directly to cancer cells which damages and kills these cells.

How should I use Lutetium Lu 177 Vipivotide Tetraxetan Injection

Lutetium Lu 177 vipivotide tetraxetan comes as a liquid to be given intravenously (into a vein) by a doctor or nurse in a hospital or clinic. It is usually injected slowly over 1 to 10 minutes or it may be infused slowly over up to 30 minutes. It may be given once every 6 weeks for up to 6 doses depending on how well your body responds to the medication and the side effects that you experience.

Your doctor will probably tell you to drink plenty of water before you receive lutetium Lu 177 vipivotide tetraxetan injection and to urinate as often as possible during the first hours after you receive a dose.

Your doctor may reduce your dose or temporarily or permanently stop your treatment. This depends on how well the medication works for you and the side effects you experience. Be sure to tell your doctor how you are feeling during your treatment with lutetium Lu 177 vipivotide tetraxetan.

Ask your pharmacist or doctor for a copy of the manufacturer's information for the patient.

Before Taking

Before receiving lutetium Lu 177 vipivotide tetraxetan injection,

  • tell your doctor and pharmacist if you are allergic to lutetium Lu 177 vipivotide tetraxetan, any other medications, or any of the ingredients in lutetium Lu 177 vipivotide tetraxetan injection. Ask your pharmacist for a list of the ingredients.
  • tell your doctor and pharmacist what other prescription and nonprescription medications, vitamins, nutritional supplements, and herbal products you are taking or plan to take. Your doctor may need to change the doses of your medications or monitor you carefully for side effects.
  • tell your doctor if you often get any type of infection or if you think you may have any type of infection now. Also tell your doctor if have previously received radiation therapy or if you have or have ever had cancer; bleeding problems; anemia (a lower than normal number of red blood cells); abnormal blood levels of sodium, potassium, or calcium; or liver or kidney problems.
  • you should know that lutetium Lu 177 vipivotide tetraxetan injection is for use only in men. If your female partner is not pregnant but could become pregnant, you and your partner must use birth control during your treatment and for 14 week after your final dose. If your partner becomes pregnant while you are receiving this medication, call your doctor. Lutetium Lu 177 vipivotide tetraxetan may harm the fetus.
  • you should know that this medication may temporarily or permanently cause infertility in men. However, you should not assume that your female partner cannot become pregnant during your treatment.
  • if you are having surgery, including dental surgery, tell the doctor or dentist that you are receiving lutetium Lu 177 vipivotide tetraxetan injection.
  • you should minimize exposing other people to radiation after you receive a dose of lutetium Lu 177 vipivotide tetraxetan by limiting close contact with other people. Stay at least 3 feet away from household contacts for 2 days and from children and pregnant women for 7 days. You should also sleep in a separate bedroom apart from household contacts for 3 days, apart from children for 7 days, and apart from pregnant women for 15 days. You should also avoid sexual activity for 7 days after receiving a dose of lutetium Lu 177 vipivotide tetraxetan injection.

What happens if I overdose?

In case of overdose, call the poison control helpline at 1-800-222-1222. Information is also available online at https://www.poisonhelp.org/help. If the victim has collapsed, had a seizure, has trouble breathing, or can't be awakened, immediately call emergency services at 911.

What special dietary instructions should I follow?

Make sure you drink plenty of water or other fluids while you are receiving lutetium Lu 177 vipivotide tetraxetan injection.

Unless your doctor tells you otherwise, continue your normal diet.

Lutetium Lu 177 Vipivotide Tetraxetan Injection side effects

Lutetium Lu 177 vipivotide tetraxetan may cause side effects. Tell your doctor if any of these symptoms are severe or do not go away:

  • dry mouth or throat
  • nausea
  • vomiting
  • diarrhea
  • constipation
  • stomach pain
  • decreased appetite
  • decreased weight
  • change in the ability to taste
  • headache
  • dry eye

Some side effects can be serious. If you experience any of these symptoms, call your doctor immediately:

  • unusual tiredness or weakness, pale skin, dizziness, shortness of breath
  • unusual bleeding or bruising
  • fever, chills, sore throat, or other signs of infection
  • mouth sores
  • increased or decreased urination
  • swelling of the arms, hands, feet, ankles, or lower legs

Lutetium Lu 177 vipivotide tetraxetan therapy may increase your risk of cancer due to exposure to radiation. Talk to your doctor about the risks of receiving this medication.

Lutetium Lu 177 vipivotide tetraxetan may cause other side effects. Call your doctor if you have any unusual problems while receiving this medication.

If you experience a serious side effect, you or your doctor may send a report to the Food and Drug Administration's (FDA) MedWatch Adverse Event Reporting program online (http://www.fda.gov/Safety/MedWatch) or by phone (1-800-332-1088).

Other uses for Lutetium Lu 177 Vipivotide Tetraxetan Injection

This medication may be prescribed for other uses; ask your doctor or pharmacist for more information.

What other information should I know?

Keep all appointments with your doctor and the laboratory. Your doctor may order certain lab tests to check your body's response to lutetium Lu 177 vipivotide tetraxetan.

Before having any laboratory test, tell your doctor and the laboratory personnel that you are receiving lutetium Lu 177 vipivotide tetraxetan injection.

It is important for you to keep a written list of all of the prescription and nonprescription (over-the-counter) medicines you are taking, as well as any products such as vitamins, minerals, or other dietary supplements. You should bring this list with you each time you visit a doctor or if you are admitted to a hospital. It is also important information to carry with you in case of emergencies.

More about Lutetium Lu 177 Vipivotide Tetraxetan Injection

Drug images
Side effects
Drug class: Drugs
Share this Article
Contents
Uses Warnings Before Taking Dosage Side effects Interactions
Related Drugs
Fidanacogene Elaparvovec
Cerave Anti-Itch
Centrum Adult
Crovalimab
Cyltezo Prefilled Syringe
Zepbound Pen
Mylanta One
Uretron Ds
Medihoney Wound And Burn Dressing
Lidotrode

Other drugs

Name Drug Class Updated
Fidanacogene Elaparvovec Drugs 03-Oct-2024
Cerave Anti-Itch Drugs 02-Oct-2024
Centrum Adult Drugs 02-Oct-2024
Crovalimab Drugs 02-Oct-2024
Cyltezo Prefilled Syringe Drugs 01-Oct-2024
Zepbound Pen Drugs 30-Sep-2024
Mylanta One Drugs 27-Sep-2024
Uretron Ds Drugs 27-Sep-2024
Medihoney Wound And Burn Dressing Drugs 26-Sep-2024
Lidotrode Drugs 26-Sep-2024
Libervant Drugs 26-Sep-2024
Moderna Covid-19 Drugs 25-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024

Categories

  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health

About US

Welcome to TheMediTary.Com

Our website provides reliable and up-to-date information on various medical topics. We empower individuals to take charge of their health by simplifying complex medical jargon and providing practical tips and advice. We prioritize the privacy and confidentiality of our users and welcome feedback to improve our services.

Website use data of FDA and other sources

DMCA.com Protection Status Truste Protection Status Trust Mark Protection Status
HONcode logo We comply with the HONcode standard for trustworthy health information.
Quick Link
  • About Us
  • Contact Us
  • Editorial Policy
  • Privacy Policy
  • Accessibility Policy
  • Terms & Conditions
  • Disclaimer
  • DMCA
  • Do Not Sell My Personal Information
  • Sitemap
  • Care Notes
  • Health Guide
  • Professional
Drugs
  • New Drugs
  • Medical Answers
  • Drugs A-Z
  • Drug Classes
  • Drug Dosage
  • Pill Identifier
  • Consumer Infor
  • Side Effects
  • Inactive Ingredients
  • Pregnancy Warnings
  • Patient Tips
  • Treatments
News
  • Latest News
  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health
Find US
  • Medium
  • Google Site
  • Blogspot
  • API
  • Reddit
  • Tumblr
  • Scoop.it
  • Substack
  • Wordpress
  • Wix
  • Behance

© 2025 TheMediTary.Com All rights reserved. Operated by